Cancer statistics: Breast cancer in situ

Elizabeth M. Ward, Carol E. Desantis, Chun Chieh Lin, Joan L. Kramer, Ahmedin Jemal, Betsy Kohler, Otis Brawley, Ted Gansler

Research output: Contribution to journalArticle

Abstract

An estimated 60,290 new cases of breast carcinoma in situ are expected to be diagnosed in 2015, and approximately 1 in 33 women is likely to receive an in situ breast cancer diagnosis in her lifetime. Although in situ breast cancers are relatively common, their clinical significance and optimal treatment are topics of uncertainty and concern for both patients and clinicians. In this article, the American Cancer Society provides information about occurrence and treatment patterns for the 2 major subtypes of in situ breast cancer in the United States - ductal carcinoma in situ and lobular carcinoma in situ - using data from the North American Association of Central Cancer Registries and the 13 oldest Surveillance, Epidemiology, and End Results registries. The authors also present an overview of in situ breast cancer detection, treatment, risk factors, and prevention and discuss research needs and initiatives.

Original languageEnglish (US)
Pages (from-to)481-495
Number of pages15
JournalCA Cancer Journal for Clinicians
Volume65
Issue number6
DOIs
StatePublished - Nov 1 2015
Externally publishedYes

Fingerprint

Breast Neoplasms
Registries
Carcinoma, Intraductal, Noninfiltrating
Uncertainty
Epidemiology
Therapeutics
Research
Neoplasms
Breast Carcinoma In Situ

Keywords

  • breast neoplasms
  • ductal carcinoma in situ
  • epidemiology
  • lobular carcinoma in situ
  • lobular neoplasia
  • race/ethnicity-specific incidence

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Ward, E. M., Desantis, C. E., Lin, C. C., Kramer, J. L., Jemal, A., Kohler, B., ... Gansler, T. (2015). Cancer statistics: Breast cancer in situ. CA Cancer Journal for Clinicians, 65(6), 481-495. https://doi.org/10.3322/caac.21321

Cancer statistics : Breast cancer in situ. / Ward, Elizabeth M.; Desantis, Carol E.; Lin, Chun Chieh; Kramer, Joan L.; Jemal, Ahmedin; Kohler, Betsy; Brawley, Otis; Gansler, Ted.

In: CA Cancer Journal for Clinicians, Vol. 65, No. 6, 01.11.2015, p. 481-495.

Research output: Contribution to journalArticle

Ward, EM, Desantis, CE, Lin, CC, Kramer, JL, Jemal, A, Kohler, B, Brawley, O & Gansler, T 2015, 'Cancer statistics: Breast cancer in situ', CA Cancer Journal for Clinicians, vol. 65, no. 6, pp. 481-495. https://doi.org/10.3322/caac.21321
Ward EM, Desantis CE, Lin CC, Kramer JL, Jemal A, Kohler B et al. Cancer statistics: Breast cancer in situ. CA Cancer Journal for Clinicians. 2015 Nov 1;65(6):481-495. https://doi.org/10.3322/caac.21321
Ward, Elizabeth M. ; Desantis, Carol E. ; Lin, Chun Chieh ; Kramer, Joan L. ; Jemal, Ahmedin ; Kohler, Betsy ; Brawley, Otis ; Gansler, Ted. / Cancer statistics : Breast cancer in situ. In: CA Cancer Journal for Clinicians. 2015 ; Vol. 65, No. 6. pp. 481-495.
@article{7d0f3311bf51467698de287ae59a821f,
title = "Cancer statistics: Breast cancer in situ",
abstract = "An estimated 60,290 new cases of breast carcinoma in situ are expected to be diagnosed in 2015, and approximately 1 in 33 women is likely to receive an in situ breast cancer diagnosis in her lifetime. Although in situ breast cancers are relatively common, their clinical significance and optimal treatment are topics of uncertainty and concern for both patients and clinicians. In this article, the American Cancer Society provides information about occurrence and treatment patterns for the 2 major subtypes of in situ breast cancer in the United States - ductal carcinoma in situ and lobular carcinoma in situ - using data from the North American Association of Central Cancer Registries and the 13 oldest Surveillance, Epidemiology, and End Results registries. The authors also present an overview of in situ breast cancer detection, treatment, risk factors, and prevention and discuss research needs and initiatives.",
keywords = "breast neoplasms, ductal carcinoma in situ, epidemiology, lobular carcinoma in situ, lobular neoplasia, race/ethnicity-specific incidence",
author = "Ward, {Elizabeth M.} and Desantis, {Carol E.} and Lin, {Chun Chieh} and Kramer, {Joan L.} and Ahmedin Jemal and Betsy Kohler and Otis Brawley and Ted Gansler",
year = "2015",
month = "11",
day = "1",
doi = "10.3322/caac.21321",
language = "English (US)",
volume = "65",
pages = "481--495",
journal = "Ca-A Cancer Journal for Clinicians",
issn = "0007-9235",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Cancer statistics

T2 - Breast cancer in situ

AU - Ward, Elizabeth M.

AU - Desantis, Carol E.

AU - Lin, Chun Chieh

AU - Kramer, Joan L.

AU - Jemal, Ahmedin

AU - Kohler, Betsy

AU - Brawley, Otis

AU - Gansler, Ted

PY - 2015/11/1

Y1 - 2015/11/1

N2 - An estimated 60,290 new cases of breast carcinoma in situ are expected to be diagnosed in 2015, and approximately 1 in 33 women is likely to receive an in situ breast cancer diagnosis in her lifetime. Although in situ breast cancers are relatively common, their clinical significance and optimal treatment are topics of uncertainty and concern for both patients and clinicians. In this article, the American Cancer Society provides information about occurrence and treatment patterns for the 2 major subtypes of in situ breast cancer in the United States - ductal carcinoma in situ and lobular carcinoma in situ - using data from the North American Association of Central Cancer Registries and the 13 oldest Surveillance, Epidemiology, and End Results registries. The authors also present an overview of in situ breast cancer detection, treatment, risk factors, and prevention and discuss research needs and initiatives.

AB - An estimated 60,290 new cases of breast carcinoma in situ are expected to be diagnosed in 2015, and approximately 1 in 33 women is likely to receive an in situ breast cancer diagnosis in her lifetime. Although in situ breast cancers are relatively common, their clinical significance and optimal treatment are topics of uncertainty and concern for both patients and clinicians. In this article, the American Cancer Society provides information about occurrence and treatment patterns for the 2 major subtypes of in situ breast cancer in the United States - ductal carcinoma in situ and lobular carcinoma in situ - using data from the North American Association of Central Cancer Registries and the 13 oldest Surveillance, Epidemiology, and End Results registries. The authors also present an overview of in situ breast cancer detection, treatment, risk factors, and prevention and discuss research needs and initiatives.

KW - breast neoplasms

KW - ductal carcinoma in situ

KW - epidemiology

KW - lobular carcinoma in situ

KW - lobular neoplasia

KW - race/ethnicity-specific incidence

UR - http://www.scopus.com/inward/record.url?scp=84947048022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947048022&partnerID=8YFLogxK

U2 - 10.3322/caac.21321

DO - 10.3322/caac.21321

M3 - Article

C2 - 26431342

AN - SCOPUS:84947048022

VL - 65

SP - 481

EP - 495

JO - Ca-A Cancer Journal for Clinicians

JF - Ca-A Cancer Journal for Clinicians

SN - 0007-9235

IS - 6

ER -